Fernando
Lecanda Cordero
Profesional Investigador
Instituto Valenciano de Oncologia
Valencia, EspañaPublications en collaboration avec des chercheurs de Instituto Valenciano de Oncologia (1)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1